TGFB1 and chronic hepatitis C virus infection: New studies demonstrate that serum TGF-β1 levels are significantly decreased after treatment with pegylated interferon alfa and ribavirin in patients with chronic hepatitis C. Additionally, serum TGF-β1 levels are mainly decreased in patients with chronic hepatitis C who achieve sustained virologic response [42].